Treatment of acute hepatitis C virus infection with interferon-α 2b and ribavirin: Case report and review of the literature

• Prif Awduron: Sunbul Mustafa (Awdur), Esen Saban (Awdur), Bayirli Derya (Awdur), Leblebicioglu Hakan (Awdur), Eroglu Cafer (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: BMC, 2002-10-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Crynodeb

<p>Abstract</p> <p/> <p>Hepatitis C virus (HCV) infection becomes chronic in about 85 % of individuals as demonstrated by the persistence of HCV. It is necesseray to treat acute hepatitis C infection. Interferon-α is generally used for the treatment of acute HCV infection.</p> <p>Case presentation</p> <p>A 55-year-old woman with a history of fatique and icter was diagnosed as acute hepatitis C virus infection. She was treated with interferon-α 2b 3 million unite sc three times in a week and ribavirin 1000 mg daily for 6 months. Within 2 weeks of therapy, the alanine aminotransferase (ALT) had became normal. At the end of the 3 months of therapy, HCV RNA was negative and remained negative 6 months after the end of interferon treatment (sustained response).</p> <p>Conclusion</p> <p>This report suggests that interferon-α 2b and ribavirin may have a role in treatment of acute hepatitis C virus infection.</p>

Disgrifiad o'r Eitem

10.1186/1476-0711-1-3
1476-0711